Skip to main content
. 2018 Aug 10;9(9):889–894. doi: 10.1021/acsmedchemlett.8b00127

Figure 2.

Figure 2

Chemical structures of the targeted tryptic Fc fragments from Herceptin (human IgG1 antibody) representing IgG1 Fc glycopeptide 1 modified with one of the scarce nonfucosylated and bisected decasaccharide (a bisected G2), and its nonbisected counterpart 2 having a biantennary nonasaccharide (a biantennary G2) listed in Figure 1.